Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age
- Autori: Maria Cristina Maggio, Luca Cantarini, Giovanni Corsello, Umberto Corpora, Rolando Cimaz
- Anno di pubblicazione: 2017
- Tipologia: Abstract in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/390109
Abstract
Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.